256 related articles for article (PubMed ID: 37502358)
1. The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer.
Tychhon B; Allen JC; Gonzalez MA; Olivas IM; Solecki JP; Keivan M; Velazquez VV; McCall EB; Tapia DN; Rubio AJ; Jordan C; Elliott D; Eiring AM
Front Med (Lausanne); 2023; 10():1209425. PubMed ID: 37502358
[TBL] [Abstract][Full Text] [Related]
2. 19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
Lara JJ; Bencomo-Alvarez AE; Gonzalez MA; Olivas IM; Young JE; Lopez JL; Velazquez VV; Glovier S; Keivan M; Rubio AJ; Dang SK; Solecki JP; Allen JC; Tapia DN; Tychhon B; Astudillo GE; Jordan C; Chandrashekar DS; Eiring AM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498916
[TBL] [Abstract][Full Text] [Related]
3. 26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Rubio AJ; Bencomo-Alvarez AE; Young JE; Velazquez VV; Lara JJ; Gonzalez MA; Eiring AM
Cells; 2021 Sep; 10(9):. PubMed ID: 34572038
[TBL] [Abstract][Full Text] [Related]
4. Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (
Haertle L; Buenache N; Cuesta Hernández HN; Simicek M; Snaurova R; Rapado I; Martinez N; López-Muñoz N; Sánchez-Pina JM; Munawar U; Han S; Ruiz-Heredia Y; Colmenares R; Gallardo M; Sanchez-Beato M; Piris MA; Samur MK; Munshi NC; Ayala R; Kortüm KM; Barrio S; Martínez-López J
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672481
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: a correlation with the proteasome status.
Matondo M; Bousquet-Dubouch MP; Gallay N; Uttenweiler-Joseph S; Recher C; Payrastre B; Manenti S; Monsarrat B; Burlet-Schiltz O
Leuk Res; 2010 Apr; 34(4):498-506. PubMed ID: 19811823
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Genome-Wide Screening Identifies Dependence on the Proteasome Subunit PSMC6 for Bortezomib Sensitivity in Multiple Myeloma.
Shi CX; Kortüm KM; Zhu YX; Bruins LA; Jedlowski P; Votruba PG; Luo M; Stewart RA; Ahmann J; Braggio E; Stewart AK
Mol Cancer Ther; 2017 Dec; 16(12):2862-2870. PubMed ID: 28958990
[TBL] [Abstract][Full Text] [Related]
7. [The proteasome - structural aspects and inhibitors: a second life for a validated drug target].
Reboud-Ravaux M
Biol Aujourdhui; 2021; 215(1-2):1-23. PubMed ID: 34397372
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the 19S ATPase proteasome subunits (Rpt1-6) conservation and their differential gene expression in Schistosoma mansoni.
Pereira-Júnior OS; Pereira RV; Silva CS; Castro-Borges W; Sá RG; Cabral FJ; Silva SH; Soares CS; Morais ER; Moreira EB; Magalhães LG; de Paula FM; Rodrigues V
Parasitol Res; 2013 Jan; 112(1):235-42. PubMed ID: 23052763
[TBL] [Abstract][Full Text] [Related]
9. Post-translationally modified S12, absent in transformed breast epithelial cells, is not associated with the 26S proteasome and is induced by proteasome inhibitor.
Thompson HG; Harris JW; Brody JP
Int J Cancer; 2004 Sep; 111(3):338-47. PubMed ID: 15221960
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic rationale and clinical evidence for the efficacy of proteasome inhibitors against indolent and mantle cell lymphomas.
Paoluzzi L; O'Connor OA
BioDrugs; 2006; 20(1):13-23. PubMed ID: 16573348
[TBL] [Abstract][Full Text] [Related]
11. Prognoses and genomic analyses of proteasome 26S subunit, ATPase (PSMC) family genes in clinical breast cancer.
Kao TJ; Wu CC; Phan NN; Liu YH; Ta HDK; Anuraga G; Wu YF; Lee KH; Chuang JY; Wang CY
Aging (Albany NY); 2021 Jul; 13(14):17970. PubMed ID: 34329194
[TBL] [Abstract][Full Text] [Related]
12. The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.
Schmidt M; Altdörfer V; Schnitte S; Fuchs AR; Kropp KN; Maurer S; Müller MR; Salih HR; Rittig SM; Grünebach F; Dörfel D
Neoplasia; 2019 Jul; 21(7):653-664. PubMed ID: 31132676
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Proteasome 26S Subunit, ATPase Family Genes as Potential Prognostic Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
Feng L; Zhang N; Luo L; Liu J; Yao Y; Gao MS; Pan J; He C
Cancer Manag Res; 2024; 16():95-111. PubMed ID: 38370535
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors in the treatment of B-cell malignancies.
Schenkein D
Clin Lymphoma; 2002 Jun; 3(1):49-55. PubMed ID: 12141956
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
Front Genet; 2022; 13():1017866. PubMed ID: 36699466
[No Abstract] [Full Text] [Related]
16. Coordinate expression of the 19S regulatory complex and evidence for ubiquitin-dependent telethonin degradation in the unloaded soleus muscle.
Heng AE; Ventadour S; Jarzaguet M; Pouch-Pélissier MN; Guezennec CY; Bigard X; Attaix D; Taillandier D
Int J Biochem Cell Biol; 2008; 40(11):2544-52. PubMed ID: 18565784
[TBL] [Abstract][Full Text] [Related]
17. Sperm-surface ATP in boar spermatozoa is required for fertilization: relevance to sperm proteasomal function.
Yi YJ; Park CS; Kim ES; Song ES; Jeong JH; Sutovsky P
Syst Biol Reprod Med; 2009; 55(2):85-96. PubMed ID: 19462288
[TBL] [Abstract][Full Text] [Related]
18. Marked clinical activity of the proteasome inhibitor bortezomib in patients with follicular and mantle-cell lymphoma.
O'Connor OA
Clin Lymphoma Myeloma; 2005 Nov; 6(3):191-9. PubMed ID: 16354324
[TBL] [Abstract][Full Text] [Related]
19. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
20. Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy.
Niewerth D; Kaspers GJ; Jansen G; van Meerloo J; Zweegman S; Jenkins G; Whitlock JA; Hunger SP; Lu X; Alonzo TA; van de Ven PM; Horton TM; Cloos J
J Hematol Oncol; 2016 Sep; 9(1):82. PubMed ID: 27599459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
